| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT07041099 A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in… |
Trial sites expanded: 11 -> 14 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-31 | NCT07738822 A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA | Phase 1/2 | Not Yet Recruiting |
| 2026-07-23 | NCT07722767 A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT04036682 | A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer | Active, Not Recruiting |
| NCT07738822 | A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA | Immune Thrombocytopenia (ITP) | Not Yet Recruiting |
| Phase 1 | |||
| NCT05143996 | CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or… | Relapsed/Refractory Acute Myeloid Leukemia (AML) | Recruiting |
| NCT06994143 | A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in… | Rheumatoid Arthritis (RA | Recruiting |
| NCT06613360 | A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in… | SLE | Recruiting |
| NCT07041099 | A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in… | Sjögren | Recruiting |
| NCT05879744 | A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin… | NHL | Active, Not Recruiting |
| NCT06381141 | A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory… | Multiple Myeloma | Active, Not Recruiting |
| NCT05117476 | A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors | Advanced Solid Tumor | Active, Not Recruiting |
| NCT07722767 | A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients | AML (Acute Myeloid Leukemia) | Not Yet Recruiting |